- Home
- ILMN
ILMN
Illumina Inc.
as 11-15-2024 4:00pm EST
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 23.1B | IPO Year: | 2000 |
| Target Price: | $160.68 | AVG Volume (30 days): | 2.0M |
| Analyst Decision: | Buy | Number of Analysts: | 20 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -9.98 | EPS Growth: | N/A |
| 52 Week Low/High: | $90.17 - $156.66 | Next Earning Date: | 11-04-2024 |
| Revenue: | $4,390,000,000 | Revenue Growth: | -1.68% |
| Revenue Growth (this year): | -2.22% | Revenue Growth (next year): | 4.00% |
Latest Illumina Inc. News
ILMN Breaking Stock News: Dive into ILMN Ticker-Specific Updates for Smart Investing
Insider Monkey
5 days ago
Illumina, Inc. (ILMN): Unlocking Growth Potential in Genetic Testing and Robotics
Zacks
6 days ago
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term
Insider Monkey
9 days ago
Here’s Why You Should Invest in Illumina (ILMN)
Argus Research
10 days ago
Analyst Report: Illumina Inc
Argus Research
10 days ago
Market Update: ILMN, CMI, GD, QCOM, APO
Zacks
10 days ago
Interpreting Illumina (ILMN) International Revenue Trends
GuruFocus.com
10 days ago
Decoding Illumina Inc (ILMN): A Strategic SWOT Insight
PR Newswire
11 days ago
Illumina To Webcast Upcoming Investor Conferences
Compare ILMN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ILMN Illumina Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.